American Portfolios Advisors’s Altimmune ALT Stock Holding History

American Portfolios Advisors’s Portfolio ALT Stock Details ALT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-250	Closed	-$2.92K	–	3534
2022 Q2	$2.92K	Hold	250	–	–	﹤0.01%	3017
2022 Q1	$1.52K	Hold	250	–	–	﹤0.01%	3280
2021 Q4	$2.29K	Hold	250	–	–	﹤0.01%	3140
2021 Q3	$2.83K	Sell	250 -500	-67%	-$6.08K	﹤0.01%	3066
2021 Q2	$7.39K	Hold	750	–	–	﹤0.01%	2652
2021 Q1	$10.6K	Hold	750	–	–	﹤0.01%	2356
2020 Q4	$8.46K	Buy	+750	New	+$8.84K	﹤0.01%	2183
2020 Q2	–	Sell	-1,000	Closed	-$3.21K	–	2843
2020 Q1	$3.21K	Hold	1,000	–	–	﹤0.01%	2248
2019 Q4	$1.89K	Hold	1,000	–	–	﹤0.01%	2586
2019 Q3	$1.95K	Hold	1,000	–	–	﹤0.01%	2523
2019 Q2	$2.38K	Hold	1,000	–	–	﹤0.01%	2427
2019 Q1	$2.9K	Buy	1,000 +900	+900%	+$2.68K	﹤0.01%	2271
2018 Q4	$206	Hold	100	–	–	﹤0.01%	2347
2018 Q3	$440	Buy	+100	New	+$1.09K	﹤0.01%	2347

Other funds holding ALT

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

American Portfolios Advisors's ALT Position: Q3 2022 in Review

American Portfolios Advisors sold out of Altimmune (ALT) in Q3 2022, closing a stake of 250 shares — an estimated $2.92K sold.

American Portfolios Advisors first reported a position in ALT in Q3 2018 and held it in 14 quarters. The position peaked at $10.6K in Q1 2021. 122 funds tracked by Wall St. Rank hold ALT as of Q3 2022.

American Portfolios Advisors reported no remaining Altimmune position as of Q3 2022 after selling out during the quarter.
American Portfolios Advisors sold 250 Altimmune shares in Q3 2022, an estimated $2.92K.
American Portfolios Advisors first reported a position in Altimmune in Q3 2018 and held it in 14 quarters.
American Portfolios Advisors's Altimmune position peaked at $10.6K in Q1 2021.
122 funds tracked by Wall St. Rank held Altimmune as of Q3 2022.

Based on American Portfolios Advisors's 13F filing for Q3 2022, filed 17 Mar 2023.